The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Extracellular purines, purinergic receptors and tumor growth
Open accessAbstract
Virtually, all tumor cells as well as all immune cells express plasma membrane receptors for extracellular nucleosides (adenosine) and nucleotides (ATP, ADP, UTP, UDP and sugar UDP). The tumor microenvironment is characterized by an unusually high concentration of ATP and adenosine. Adenosine is a major determinant of the immunosuppressive tumor milieu. Sequential hydrolysis of extracellular ATP catalyzed by CD39 and CD73 is the main pathway for the generation of adenosine in the tumor interstitium. Extracellular ATP and adenosine mold both host and tumor responses. Depending on the specific receptor activated, extracellular purines mediate immunosuppression or immunostimulation on the host side, and growth stimulation or cytotoxicity on the tumor side. Recent progress in this field is providing the key to decode this complex scenario and to lay the basis to harness the potential benefits for therapy. Preclinical data show that targeting the adenosine-generating pathway (that is, CD73) or adenosinergic receptors (that is, A2A) relieves immunosuppresion and potently inhibits tumor growth. On the other hand, growth of experimental tumors is strongly inhibited by targeting the P2X7 ATP-selective receptor of cancer and immune cells. This review summarizes the recent data on the role played by extracellular purines (purinergic signaling) in host-tumor interaction and highlights novel therapeutic options stemming from recent advances in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Immunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Drury, A. N., & Szent-Györgyi, A. (1929) · The Journal of Physiology · doi:10.1113/jphysiol.1929.sp002608 · Cited by 1,487
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrin, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,431
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
Self-citationOhta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP
Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., & Buell, G. (1994) · Nature · doi:10.1038/371516a0 · Cited by 1,029
Extracellular metabolism of ATP and other nucleotides
Zimmermann, H. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000309 · Cited by 990
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor
Brake, A. J., Wagenbach, M. J., & Julius, D. (1994) · Nature · doi:10.1038/371519a0 · Cited by 919
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 902
P2X receptors as cell-surface ATP sensors in health and disease
Khakh, B. S., & Alan North, R. (2006) · Nature · doi:10.1038/nature04886 · Cited by 856
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
Koizumi, S., Shigemoto-Mogami, Y., Nasu-Tada, K., Shinozaki, Y., Ohsawa, K., Tsuda, M., Joshi, B. V., Jacobson, K. A., Kohsaka, S., & Inoue, K. (2007) · Nature · doi:10.1038/nature05704 · Cited by 802
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N. A., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15337 · Cited by 679
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002599 · Cited by 668
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215337 · Cited by 660
Schumacher, D., Strilic, B., Sivaraj, K. K., Wettschureck, N., & Offermanns, S. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.008 · Cited by 630
Pathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 611
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Hatfield, S. M., Kjaergaard, J., Lukashev, D., Schreiber, T. H., Belikoff, B., Abbott, R., Sethumadhavan, S., Philbrook, P., Ko, K., Cannici, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1260 · Cited by 600
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Extracellular adenosine triphosphate and adenosine in cancer
Stagg, J., & Smyth, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.292 · Cited by 571
Cloning and functional expression of a brain G‐protein‐coupled ATP receptor
Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., Burnstock, G., & Barnard, E. A. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81397-i · Cited by 548
Signaling at Purinergic P2X Receptors
Surprenant, A., & North, R. A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100630 · Cited by 547
Immune suppressive mechanisms in the tumor microenvironment
Munn, D. H., & Bronte, V. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.10.009 · Cited by 519
Activation and Regulation of Purinergic P2X Receptor Channels
Coddou, C., Yan, Z., Obsil, T., Huidobro-Toro, J. P., & Stojilkovic, S. S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003129 · Cited by 493
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Loi, S., Pommey, S., Haibe-Kains, B., Beavis, P. A., Darcy, P. K., Smyth, M. J., & Stagg, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222251110 · Cited by 492
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Allard, B., Pommey, S., Smyth, M. J., & Stagg, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0545 · Cited by 458
Dopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Le Crom, S., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 445
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Wilhelm, K., Ganesan, J., Müller, T., Dürr, C., Grimm, M., Beilhack, A., Krempl, C. D., Sorichter, S., Gerlach, U. V., Jüttner, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2242 · Cited by 435
Self-citation(1997) · PubMed · Cited by 433
Pore dilation of neuronal P2X receptor channels
Virginio, C., MacKenzie, A., Rassendren, F. A., North, R. A., & Surprenant, A. (1999) · Nature Neuroscience · doi:10.1038/7225 · Cited by 413
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
Stagg, J., Divisekera, U., Duret, H., Sparwasser, T., Teng, M. W. L., Darcy, P. K., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4246 · Cited by 401
Extracellular Metabolic Energetics Can Promote Cancer Progression
Loo, J. M., Scherl, A., Nguyen, A., Man, F. Y., Weinberg, E., Zeng, Z., Saltz, L., Paty, P. B., & Tavazoie, S. F. (2015) · Cell · doi:10.1016/j.cell.2014.12.018 · Cited by 393
Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
The P2X 7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X 7 R Pore
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374
Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds
Khakh, B. S., Bao, X. R., Labarca, C., & Lester, H. A. (1999) · Nature Neuroscience · doi:10.1038/7233 · Cited by 365
The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29
Young, J. D., Yao, S. Y. M., Baldwin, J. M., Cass, C. E., & Baldwin, S. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.05.007 · Cited by 356
Expression of P2X7 Receptor Increases In Vivo Tumor Growth
Adinolfi, E., Raffaghello, L., Giuliani, A. L., Cavazzini, L., Capece, M., Chiozzi, P., Bianchi, G., Kroemer, G., Pistoia, V., & Di Virgilio, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1947 · Cited by 347
Self-citationPurinergic signalling and cancer
Burnstock, G., & Di Virgilio, F. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9372-5 · Cited by 316
Self-citationTargeting Cancer-Derived Adenosine:New Therapeutic Approaches
Young, A., Mittal, D., Stagg, J., & Smyth, M. J. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0341 · Cited by 310
Cekic, C., Day, Y.-J., Sag, D., & Linden, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3583 · Cited by 304
Yegutkin, G. G. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.953627 · Cited by 299
Vesicular and conductive mechanisms of nucleotide release
Lazarowski, E. R. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9304-9 · Cited by 297
A Novel Recombinant Plasma Membrane-targeted Luciferase Reveals a New Pathway for ATP Secretion
Pellegatti, P., Falzoni, S., Pinton, P., Rizzuto, R., & Di Virgilio, F. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0222 · Cited by 297
Self-citationBeigi, R., Kobatake, E., Aizawa, M., & Dubyak, G. R. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.1.c267 · Cited by 297
Purines, Purinergic Receptors, and Cancer
Di Virgilio, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1600 · Cited by 288
Self-citationChemotherapy induces ATP release from tumor cells
Martins, I., Tesniere, A., Kepp, O., Michaud, M., Schlemmer, F., Senovilla, L., Séror, C., Métivier, D., Perfettini, J.-L., Zitvogel, L., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.22.10026 · Cited by 278
Virgilio, F. D., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J. M., Venketaraman, V., & Baricordi, O. R. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400341 · Cited by 278
Adinolfi, E., Callegari, M. G., Ferrari, D., Bolognesi, C., Minelli, M., Wieckowski, M. R., Pinton, P., Rizzuto, R., & Di Virgilio, F. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1025 · Cited by 275
Self-citationMicroelectrode Biosensor for Real-Time Measurement of ATP in Biological Tissue
Llaudet, E., Hatz, S., Droniou, M., & Dale, N. (2005) · Analytical Chemistry · doi:10.1021/ac048106q · Cited by 267
Medicinal chemistry of adenosine, P2Y and P2X receptors
Jacobson, K. A., & Müller, C. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.001 · Cited by 262
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Ryzhov, S., Novitskiy, S. V., Goldstein, A. E., Biktasova, A., Blackburn, M. R., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101225 · Cited by 261
Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M. G., Sandonà, D., Markwardt, F., Schmalzing, G., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-153601 · Cited by 254
Self-citationInosine binds to A3 adenosine receptors and stimulates mast cell degranulation.
Jin, X., Shepherd, R. K., Duling, B. R., & Linden, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119833 · Cited by 251
ATP induces nucleotide permeability in rat mast cells
COCKCROFT, S., & GOMPERTS, B. D. (1979) · Nature · doi:10.1038/279541a0 · Cited by 251
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Mittal, D., Young, A., Stannard, K., Yong, M., Teng, M. W. L., Allard, B., Stagg, J., & Smyth, M. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0957 · Cited by 245
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
Eltzschig, H. K., Köhler, D., Eckle, T., Kong, T., Robson, S. C., & Colgan, S. P. (2009) · Blood · doi:10.1182/blood-2008-06-165746 · Cited by 244
The A3 Adenosine Receptor: History and Perspectives
Borea, P. A., Varani, K., Vincenzi, F., Baraldi, P. G., Tabrizi, M. A., Merighi, S., & Gessi, S. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008540 · Cited by 244
Purinergic signalling: from discovery to current developments
Burnstock, G. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2013.071951 · Cited by 237
Adenosine receptors and cancer
Gessi, S., Merighi, S., Sacchetto, V., Simioni, C., & Borea, P. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.09.020 · Cited by 224
Jelassi, B., Chantôme, A., Alcaraz-Pérez, F., Baroja-Mazo, A., Cayuela, M. L., Pelegrin, P., Surprenant, A., & Roger, S. (2011) · Oncogene · doi:10.1038/onc.2010.593 · Cited by 209
Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity
Weber, F. C., Esser, P. R., Müller, T., Ganesan, J., Pellegatti, P., Simon, M. M., Zeiser, R., Idzko, M., Jakob, T., & Martin, S. F. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092489 · Cited by 207
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
Adinolfi, E., Melchiorri, L., Falzoni, S., Chiozzi, P., Morelli, A., Tieghi, A., Cuneo, A., Castoldi, G., Di Virgilio, F., & Baricordi, O. R. (2002) · Blood · doi:10.1182/blood.v99.2.706 · Cited by 204
Self-citationENTPD1/CD39 is a promising therapeutic target in oncology
Bastid, J., Cottalorda-Regairaz, A., Alberici, G., Bonnefoy, N., Eliaou, J.-F., & Bensussan, A. (2013) · Oncogene · doi:10.1038/onc.2012.269 · Cited by 202
Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
Cekic, C., Sag, D., Li, Y., Theodorescu, D., Strieter, R. M., & Linden, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101845 · Cited by 201
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Leclerc, B. G., Charlebois, R., Chouinard, G., Allard, B., Pommey, S., Saad, F., & Stagg, J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1181 · Cited by 200
Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line.
Steinberg, T. H., & Silverstein, S. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61477-2 · Cited by 196
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
Sitkovsky, M. V. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.002 · Cited by 193
The A3 Adenosine Receptor Is Highly Expressed in Tumor versus Normal Cells
Madi, L., Ochaion, A., Rath-Wolfson, L., Bar-Yehuda, S., Erlanger, A., Ohana, G., Harish, A., Merimski, O., Barer, F., & Fishman, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0651 · Cited by 189
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes
Baricordi, O., Ferrari, D., Melchiorri, L., Chiozzi, P., Hanau, S., Chiari, E., Rubini, M., & Di Virgilio, F. (1996) · Blood · doi:10.1182/blood.v87.2.682.bloodjournal872682 · Cited by 187
Self-citationAmoroso, F., Capece, M., Rotondo, A., Cangelosi, D., Ferracin, M., Franceschini, A., Raffaghello, L., Pistoia, V, Varesio, L., & Adinolfi, E. (2015) · Oncogene · doi:10.1038/onc.2014.444 · Cited by 185
Self-citationMechanistic explanation for platelet contribution to cancer metastasis
Stegner, D., Dütting, S., & Nieswandt, B. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50025-4 · Cited by 179
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A. L., Rotondo, A., Sarti, A. C., Bonora, M., Syberg, S., Corigliano, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1259 · Cited by 176
Self-citationDi Virgilio, F., Bronte, V, Collavo, D., & Zanovello, P. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1955 · Cited by 175
Self-citationA Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
Wilson, F. H., Johannessen, C. M., Piccioni, F., Tamayo, P., Kim, J. W., Van Allen, E. M., Corsello, S. M., Capelletti, M., Calles, A., Butaney, M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.005 · Cited by 172
Tafani, M., Schito, L., Pellegrini, L., Villanova, L., Marfe, G., Anwar, T., Rosa, R., Indelicato, M., Fini, M., Pucci, B., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr101 · Cited by 170
Gessi, S., Cattabriga, E., Avitabile, A., Gafa’, R., Lanza, G., Cavazzini, L., Bianchi, N., Gambari, R., Feo, C., Liboni, A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1134-03 · Cited by 167
The P2X7 receptor is a key modulator of aerobic glycolysis
Amoroso, F., Falzoni, S., Adinolfi, E., Ferrari, D., & Virgilio, F. D. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.105 · Cited by 165
Self-citationP2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation
Bours, M. J. L. (2011) · Frontiers in Bioscience · doi:10.2741/235 · Cited by 160
Merighi, S., Mirandola, P., Milani, D., Varani, K., Gessi, S., Klotz, K., Leung, E., Baraldi, P. G., & Borea, P. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00111.x · Cited by 158
Raffaghello, L., Chiozzi, P., Falzoni, S., Virgilio, F. D., & Pistoia, V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3185 · Cited by 158
Iannone, R., Miele, L., Maiolino, P., Pinto, A., & Morello, S. (2013) · Neoplasia · doi:10.1593/neo.131748 · Cited by 156
Regulation of Lymphocyte Function by Adenosine
Linden, J. M., & Cekic, C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226837 · Cited by 155
A role for P2X 7 in microglial proliferation
Bianco, F., Ceruti, S., Colombo, A. V., Fumagalli, M., Ferrari, D., Pizzirani, C., Matteoli, M., Virgilio, F. D., Abbracchio, M. P., & Verderio, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04101.x · Cited by 148
de Rijke, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24832 · Cited by 143
P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release
Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., & Pelegrín, P. (2012) · The FASEB Journal · doi:10.1096/fj.12-205765 · Cited by 142
Greig, A. V. H., Burnstock, G., Linge, C., Healy, V. C., Lim, P., Clayton, E., Rustin, M. H. A., & McGrouther, D. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12379.x · Cited by 142
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
Kumar, V. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9349-9 · Cited by 141
Detecting adenosine triphosphate in the pericellular space
Falzoni, S., Donvito, G., & Di Virgilio, F. (2013) · Interface Focus · doi:10.1098/rsfs.2012.0101 · Cited by 136
Self-citationATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
Bianchi, G., Vuerich, M., Pellegatti, P., Marimpietri, D., Emionite, L., Marigo, I., Bronte, V., Virgilio, F. D., Pistoia, V., & Raffaghello, L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.109 · Cited by 133
Giannuzzo, A., Pedersen, S. F., & Novak, I. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0472-4 · Cited by 133
Jiang, L., Rassendren, F., Mackenzie, A. B., Zhang, Y.-H., Surprenant, A., & North, R. A. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2005 · Cited by 132
P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells
Qiu, Y., Li, W., Zhang, H., Liu, Y., Tian, X., & Fang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114371 · Cited by 131
Coutinho‐Silva, R., Welter-Stahl, L., Cheung, K., de Campos, N. E., de Souza, C., Ojcius, D. M., & Burnstock, G. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00211.2004 · Cited by 127
Role of TGF-β Signaling in Generation of CD39+CD73+ Myeloid Cells in Tumors
Ryzhov, S. V., Pickup, M. W., Chytil, A., Gorska, A. E., Zhang, Q., Owens, P., Feoktistov, I., Moses, H. L., & Novitskiy, S. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400578 · Cited by 126
P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells
Li, W.-H., Qiu, Y., Hq, Z., Liu, Y., You, J.-F., Tian, X.-X., & Wg, F. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.484 · Cited by 125
P2X7 receptors stimulate AKT phosphorylation in astrocytes
Jacques-Silva, M. C., Rodnight, R., Lenz, G., Liao, Z., Kong, Q., Tran, M., Kang, Y., Gonzalez, F. A., Weisman, G. A., & Neary, J. T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705685 · Cited by 124
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
Künzli, B. M., Bernlochner, M.-I., Rath, S., Käser, S. A., Csizmadia, E., Enjyoji, K., Cowan, P. J., d’Apice, A. J. F., Dwyer, K. M., Rosenberg, R., et al. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9228-9 · Cited by 123
Physical basis of apparent pore dilation of ATP-activated P2X receptor channels
Li, M., Toombes, G. E. S., Silberberg, S. D., & Swartz, K. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4120 · Cited by 119
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 119
Self-citationHofman, P. M., Cherfils‐Vicini, J., Bazin, M., Ilié, M., Juhel, T., Hébuterne, X., Gilson, É., Schmid‐Alliana, A., Boyer, O., Adriouch, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1778 · Cited by 118
P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway
Xia, J., Yu, X., Tang, L. P., LI, G., & He, T. (2015) · Oncology Reports · doi:10.3892/or.2015.3979 · Cited by 116
Adinolfi, E., Callegari, M. G., Cirillo, M., Pinton, P., Giorgi, C., Cavagna, D., Rizzuto, R., & Virgilio, F. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805805200 · Cited by 115
Self-citationHill, L. M., Gavala, M. L., Lenertz, L. Y., & Bertics, P. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001298 · Cited by 107
Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
Jackson, S. W., Hoshi, T., Wu, Y., Sun, X., Enjyoji, K., Cszimadia, E., Sundberg, C., & Robson, S. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070190 · Cited by 104
Fishman, P., Bar‐Yehuda, S., Ohana, G., Barer, F., Ochaion, A., Erlanger, A., & Madi, L. (2003) · Oncogene · doi:10.1038/sj.onc.1207355 · Cited by 104
Roger, S., Jelassi, B., Couillin, I., Pelegrín, P., Besson, P., & Jiang, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.029 · Cited by 103
Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
Giuliani, A. L., Colognesi, D., Ricco, T., Roncato, C., Capece, M., Amoroso, F., Wang, Q., Marchi, E. D., Gartland, A., Virgilio, F. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107224 · Cited by 103
Self-citationThe extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration
Rossi, L., Manfredini, R., Bertolini, F., Ferrari, D., Fogli, M., Zini, R., Salati, S., Salvestrini, V., Gulinelli, S., Adinolfi, E., et al. (2006) · Blood · doi:10.1182/blood-2006-01-035634 · Cited by 101
Self-citationChadet, S., Jelassi, B., Wannous, R., Angoulvant, D., Chevalier, S., Besson, P., & Roger, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt493 · Cited by 99
Adenosine A3 Receptor Suppresses Prostate Cancer Metastasis by Inhibiting NADPH Oxidase Activity
Jajoo, S., Mukherjea, D., Watabe, K., & Ramkumar, V. (2009) · Neoplasia · doi:10.1593/neo.09744 · Cited by 97
Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
Bowser, J. L., Blackburn, M. R., Shipley, G. L., Molina, J. G., Dunner, K., & Broaddus, R. R. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79380 · Cited by 97
Xie, R., Xu, J., Wen, G., Jin, H. D., Liu, X., Yang, Y., Ji, B., Jiang, Y., Song, P., Dong, H. F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540047 · Cited by 96
The Antibiotic Polymyxin B Modulates P2X7 Receptor Function
Ferrari, D., Pizzirani, C., Adinolfi, E., Forchap, S., Sitta, B., Turchet, L., Falzoni, S., Minelli, M., Baricordi, R., & Virgilio, F. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4652 · Cited by 95
Self-citationLê, K., Paquet, M., Nouel, D., Babinski, K., & Séguéla, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01380-x · Cited by 95
CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study
Stemmer, S. M., Benjaminov, O., Medalia, G., Ciuraru, N. B., Silverman, M. H., Bar‐Yehuda, S., Fishman, S., Harpaz, Z., Farbstein, M., Cohen, S., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0211 · Cited by 93
P2X2 and P2X5 Subunits Define a New Heteromeric Receptor with P2X7-Like Properties
Compan, V., Ulmann, L., Stelmashenko, O., Chemin, J., Chaumont‐Dubel, S., & Rassendren, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6332-11.2012 · Cited by 89
Ntantie, E., Gonyo, P., Lorimer, E., Hauser, A. D., Schuld, N. J., McAllister, D. M., Kalyanaraman, B., Dwinell, M. B., Auchampach, J. A., & Williams, C. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003374 · Cited by 87
Wiley, J. S., Chen, J. R., Snook, M. B., & Jamieson, G. P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13172.x · Cited by 85
Takai, E., Tsukimoto, M., Harada, H., & Kojima, S. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9411-x · Cited by 85
MacKenzie, W. M., Hoskin, D. W., & Blay, J. (1994) · PubMed · Cited by 84
Adenosine A2b receptor promotes progression of human oral cancer
Kasama, H., Sakamoto, Y., Kasamatsu, A., Okamoto, A., Koyama, T., Minakawa, Y., Ogawara, K., Yokoe, H., Shiiba, M., Tanzawa, H., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1577-2 · Cited by 83
Longhi, M. S., Robson, S. C., Bernstein, S. H., Serra, S., & Deaglio, S. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0991-z · Cited by 83
Rigato, C., Swinnen, N., Buckinx, R., Couillin, I., Mangin, J., Rigo, J., Legendre, P., & Corronc, H. L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1042-12.2012 · Cited by 83
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling
Rossi, L., Salvestrini, V., Ferrari, D., Virgilio, F. D., & Lemoli, R. M. (2012) · Blood · doi:10.1182/blood-2012-04-422378 · Cited by 83
Mirza, A., Basso, A., Black, S., Malkowski, M. G., Kwee, L., Patcher, J. A., Lachowicz, J. E., Wang, Y., & Liu, S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.12.2196 · Cited by 82
P2X Receptors and Inflammation
Virgilio, F. D. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666141210155311 · Cited by 81
Hoskin, D. W., Butler, J. J., Drapeau, D., Haeryfar, S. M. M., & Blay, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10325 · Cited by 76
Continuous detection of extracellular ATP on living cells by using atomic force microscopy
Schneider, S. W., Egan, M. E., Jena, B. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12180 · Cited by 76
Vázquez‐Cuevas, F. G., Martínez-Ramírez, A. S., Robles-Martínez, L., Garay, E., García-Carrancá, A. M., Pérez‐Montiel, D., Castañeda-García, C., & Arellano, R. O. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24867 · Cited by 75
Corriden, R., Insel, P. A., & JUNGER, W. G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00271.2007 · Cited by 75
Joo, Y. N., Jin, H., Eun, S. Y., Park, S. W., Chang, K. C., & Kim, H. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2427 · Cited by 74
Gómez‐Villafuertes, R., García-Huerta, P., Díaz‐Hernandéz, J. I., & Miras‐Portugal, M. T. (2015) · Scientific Reports · doi:10.1038/srep18417 · Cited by 72
P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway
Li, W.-H., Qiu, Y., Zhang, H., Tian, X., & Fang, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133165 · Cited by 71
Lin, Z., Yin, P., Reierstad, S., O'Halloran, M., Coon, J. S., Pearson, E. K., Mutlu, G. M., & Bulun, S. E. (2009) · Oncogene · doi:10.1038/onc.2009.409 · Cited by 69
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors
Gessi, S., Sacchetto, V., Fogli, E., Merighi, S., Varani, K., Baraldi, P. G., Tabrizi, M. A., Leung, E., MacLennan, S., & Borea, P. A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.009 · Cited by 68
Emerging Roles of P2X Receptors in Cancer
Adinolfi, E., Capece, M., Amoroso, F., Marchi, E. D., & Franceschini, A. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141012172913 · Cited by 63
Self-citationGhalali, A., Wiklund, F. E., Zheng, H., Stenius, U., & Högberg, J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu019 · Cited by 63
High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
Aliagas, E., Vidal, A., Texidó, L., Ponce, J., Condom, E., & Martín-Satué, M. (2014) · Mediators of Inflammation · doi:10.1155/2014/509027 · Cited by 61
Detecting ATP Release by a Biosensor Method
Hayashi, S., Hazama, A., Dutta, A. K., Sabirov, R. Z., & Okada, Y. (2004) · Science s STKE · doi:10.1126/stke.2582004pl14 · Cited by 56
Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias
Chong, J.-H., Zheng, G., Zhu, X., Guo, Y., Wang, L., Ma, C.-H., Liu, S., Xu, L., Lin, Y., & Wu, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.087 · Cited by 54
Effect of extracellular ATP on the growth of hormone‐refractory prostate cancer in vivo
Shabbir, M., Thompson, C. S., Jarmulowiczc, M., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07578.x · Cited by 54
Corriden, R., Kilpatrick, L. E., Kellam, B., Briddon, S. J., & Hill, S. J. (2014) · The FASEB Journal · doi:10.1096/fj.13-247270 · Cited by 53
Bergamin, L. S., Braganhol, E., Figueiró, F., Casali, É. A., Zanin, R. F., Sévigny, J., & Battastini, A. M. O. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25018 · Cited by 50
Flament (2009) · Oncology Reports · doi:10.3892/or_00000311 · Cited by 49
Cappellari, A. R., Rockenbach, L., Dietrich, F., Clarimundo, V. S., Glaser, T., Braganhol, E., Abujamra, A. L., Roesler, R., Ulrich, H., & Battastini, A. M. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047468 · Cited by 48
Maynard, J. P., Lee, J., Sohn, B. H., Yu, X., Lopez-Terrada, D. H., Finegold, M. J., Goss, J. A., & Thevananther, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6240 · Cited by 47
Allsopp, R. C., & Evans, R. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642033 · Cited by 42
Kotnis, S., Bingham, B., Vasilyev, D. V., Miller, S. W., Bai, Y., Yeola, S. W., Chanda, P. K., Bowlby, M. R., Kaftan, E. J., Samad, T. A., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.063636 · Cited by 42
Norde, W. J., Overes, I. M., Maas, F., Fredrix, H., Vos, J. C. M., Kester, M. G. D., van der Voort, R., Jedema, I., Falkenburg, J. H. F., Schattenberg, A. V. M. B., et al. (2008) · Blood · doi:10.1182/blood-2008-04-153825 · Cited by 42
A novel role for P2X7 receptor signalling in the survival of mouse embryonic stem cells
Thompson, B. A. N., Storm, M. P., Hewinson, J., Hogg, S. L., Welham, M. J., & Mackenzie, A. B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.012 · Cited by 38
Overes, I. M., de Rijke, B., van Horssen-Zoetbrood, A., Fredrix, H., de Graaf, A. O., Jansen, J. H., van Krieken, J. H., Raymakers, R. A. P., van der Voort, R., de Witte, T. M., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07125.x · Cited by 38
Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues
Mousavi, S., Panjehpour, M., Izadpanahi, M. H., & Aghaei, M. (2015) · The Prostate · doi:10.1002/pros.22955 · Cited by 34
The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis
Tung, H., Lee, F., Wang, S.-S., Tsai, M.-H., Lee, J.-Y., Huo, T., Huang, H., Chuang, C., Lin, H., & Lee, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124654 · Cited by 34
Solini, A., Simeon, V., Derosa, L., Orlandi, P., Rossi, C., Fontana, A., Galli, L., Desidero, T. D., Fioravanti, A., Lucchesi, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4926 · Cited by 32
Yang, G., Zhang, S., Zhang, Y., Zhou, Q., Peng, S., Zhang, T., Yang, C., Zhu, Z., & Zhang, F. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-53 · Cited by 32
Sun, S. H. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8120-x · Cited by 29
Fang, J., Chen, X., Wang, S., Xie, T., Du, X., Liu, H., Wang, S., Li, X., Chen, J., Zhang, B., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1016663 · Cited by 27
P2X7Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis
Kwon, J. H., Nam, E. S., Shin, H. S., et al. (2014) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2014.48.1.30 · Cited by 23
Cited by
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Metabolic Interactions in the Tumor Microenvironment
Lyssiotis, C. A., & Kimmelman, A. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.003 · Cited by 853
Targeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.86 · Cited by 840
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Di Virgilio, F., Sarti, A. C., Falzoni, S., De Marchi, E., & Adinolfi, E. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0037-0 · Cited by 723
Self-citation
Metadata
- Authors
- Di Virgilio, F., & Adinolfi, E.
- Venue
- Oncogene
- Published
- 2016-06-20
- Volume
- 36
- Issue
- 3
- Pages
- 293-303
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2462605598
- Cited by
- 559
- References
- 167
- FWCI
- 38.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.